Top Headlines

News

FDA Approves Luspatercept-aamt for Anemia in Patients with Myelodysplastic Syndromes

September 20, 2023

News

On August 28, 2023, the U.S. Food and Drug Administration

Expert Opinion: Children’s Oncology Group AALL1331: Phase III Trial of Blinatumomab in Children, Adolescents, and Young Adults With Low-Risk B-Cell ALL in First Relapse

August 24, 2023

Hematologic Malignancies

By Akshat Jain MD, MPH Hematology Oncology and Cellular Therapy

FDA Approves HEPZATO KIT for Uveal Melanoma with Unresectable Hepatic Metastases

August 17, 2023

New Approvals/New Drug Applications

By Dr. Anish Shah Bronx-Lebanon Hospital On August 14,

FDA Approves Elranatamab-bcmm for Multiple Myeloma with Relapsed or Refractory Status

August 17, 2023

New Approvals/New Drug Applications

By Dr. Anish Shah Bronx-Lebanon Hospital On August 14,

FDA approves niraparib and abiraterone acetate plus prednisone for metastatic prostate cancer With BRCA Mutation

August 15, 2023

New Approvals/New Drug Applications

By Dr. Anish Shah Bronx Lebanon Hospital On August

FDA Approves Talquetamab-Tgvs For Adults with Relapsed Or Refractory Multiple Myeloma Patients with at least Four Prior Lines of Therapy

August 14, 2023

New Approvals/New Drug Applications

By Dr. Anish Shah Bronx Lebanon Hospital On August

Biomarker Testing in Cancer

August 11, 2023

Patient Corner

By Dr. Dipesh Uprety Karmanos Cancer Institute & Dr.

FDA grants approval to Pralsetinib for NSCLC With RET Fusion Mutation

August 9, 2023

New Approvals/New Drug Applications

By Dr. Anish Shah Bronx-Lebanon Hospital On August 9,

Cancer Types

Video News

Overview of KEYNOTE-671 & NADIM II

By Dr. Lei Deng University of Washington & Fred Hutch Watch

See full post

Overview of the Quantum First Trial with Dr. Talha Badar

Dr. Talha Badar of Mayo Clinic discusses the results of Quantum First, a randomized, phase

See full post

Expert Opinion in Multiple Myeloma with Dr. Shaji Kumar

Dr. Richa Parikh interviewed Dr. Shaji Kumar of Mayo Clinic about his recommendations for the

See full post

Interview with Dr. Chadi Nabhan

Dr. Dipesh Uprety interviewed Dr. Chadi Nabhan about his new book, Toxic Exposure. Watch the

See full post

IMBRAVE-151, A Phase II, Randomized, Double-Blind Placebo-Controlled Study of Atezolizumab with or without Bevacizumab in Combination with Cisplatin plus Gemcitabine in Patients with Untreated, Advanced Biliary Tract Cancer

Dr. Ghassan Abou-Alfa of Memorial Sloan Kettering Cancer Center shares a recent abstract from ASCO

See full post

Suggestions

Top Headlines

News

Cancer Types

Video News